Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function
- Authors: Falkovskaya A.Y.1, Mordovin V.F.1, Pekarskiy S.E.1, Ripp T.M.1, Manukyan M.A.1, Lichikaki V.A.1, Zyubanova I.V.1, Sitkova E.S.1, Gusakova A.M.1, Ryabova T.R.1
-
Affiliations:
- Cardiology Research Institute, Tomsk National Research Medical Center
- Issue: Vol 93, No 1 (2021)
- Pages: 49-58
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/61888
- DOI: https://doi.org/10.26442/00403660.2021.01.200593
- ID: 61888
Cite item
Full Text
Abstract
Aim. To determine the prevalence of refractory hypertension (RfH) in patients with and without type 2 diabetes mellitus (DM), as well as to evaluate whether diabetic patients with RfH significant differ from those with uncontrolled resistant hypertension (RH) in clinical phenotype, metabolic profile and endothelial function.
Materials and methods. The study included 193 patients with RH: RH 74 patients with diabetes and 119 patients without DM. Uncontrolled RH and RfH were defined by the presence of uncontrolled blood pressure – BP (≥140 and/or 90 mm Hg) despite the use of >3 but <5 antihypertensive drugs (for RH) and ≥5 antihypertensive drugs, including a mineralocorticoid receptor antagonist (for RfH). Clinical examination, lab tests were performed. Flow-mediated dilation (FMD) and vasoreactivity of middle cerebral artery (MCA) using both breath-holding and hyperventilation test were measured by high-resolution ultrasound.
Results. The prevalence of refractory hypertension in patients with and without DM was similar (30% vs 28%, respectively). No differences in BP levels, data of echocardiography and clinical phenotype were found between the diabetic groups, but value of HOMA index, plasma resistin level and postprandial glycaemia were higher in patients with RfH. FMD and MCA reactivity to the breath-holding test were worse in patients with RfH, and they had a more pronounced vasoconstrictor response of MCA to the hyperventilation test compared to patients with RH.
Conclusion. The prevalence of RfH is the same in patients with and without diabetes. Diabetic patients with refractory hypertension have a more unfavorable metabolic profile and greater impairment of endothelial function than patients with uncontrolled resistant hypertension.
Full Text
##article.viewOnOriginalSite##About the authors
Alla Y. Falkovskaya
Cardiology Research Institute, Tomsk National Research Medical Center
Author for correspondence.
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0002-5638-3034
к.м.н., ст. науч. сотр. отд-ния артериальных гипертоний
Russian Federation, TomskVictor F. Mordovin
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0002-2238-4573
д.м.н., проф., рук. отд-ния артериальных гипертоний
Russian Federation, TomskStanislav E. Pekarskiy
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0002-4008-4021
д.м.н., вед. науч. сотр. отд-ния хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции
Russian Federation, TomskTatiana M. Ripp
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0001-5898-0361
д.м.н., вед. науч. сотр. отд-ния артериальных гипертоний
Russian Federation, TomskMushegh A. Manukyan
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0003-3577-1895
аспирант отд-ния артериальных гипертоний
Russian Federation, TomskValeria A. Lichikaki
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0003-4066-869X
к.м.н., науч. сотр. отд-ния артериальных гипертоний
Russian Federation, TomskIrina V. Zyubanova
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0001-6995-9875
к.м.н., мл. науч. сотр. отд-ния артериальных гипертоний
Russian Federation, TomskEkaterina S. Sitkova
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0002-0988-3642
к.м.н., врач отд-ния хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции
Russian Federation, TomskAnna M. Gusakova
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0002-3147-3025
к.м.н., науч. сотр. отд-ния функциональной и лабораторной диагностики
Russian Federation, TomskTamara R. Ryabova
Cardiology Research Institute, Tomsk National Research Medical Center
Email: alla@cardio-tomsk.ru
ORCID iD: 0000-0001-8573-5695
к.м.н., ст. науч. сотр. отд-ния функциональной и лабораторной диагностики
Russian Federation, TomskReferences
- Dudenbostel T, Siddiqui M, Gharpure N, Calhoun DA. Refractory versus resistant hypertension: Novel distinctive phenotypes. J Nat Sci. 2017;3(9):e430.
- Аксенова А.В., Есаулова Т.Е., Сивакова О.А., Чазова И.Е. Резистентная и рефрактерная артериальные гипертонии: сходства и различия, новые подходы к диагностике и лечению. Системные гипертензии. 2018;15(3):11-3 [Aksenova AV, Esaulova TE, Sivakova OA, Chazova IE. Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment. Systemic Hypertension. 2018;15(3):11-3 (In Russ.)]. doi: 10.26442/2075-082X_2018.3.11-13
- Кузьмин О.Б., Бучнева Н.В., Жежа В.В., Сердюк С.В. Неконтролируемая артериальная гипертензия: почка, нейрогормональный дисбаланс и подходы к антигипертензивной лекарственной терапии. Кардиология. 2019;59(12):64-71 [Kuzmin OB, Buchneva NN, Zhezha VV, Serdyuk SV. Uncontrolled arterial hypertension: kidney, neurohormonal imbalance, and approaches to antihypertensive drug therapy. Kardiologiia. 2019;59(12):64-71 (In Russ.)]. doi: 10.18087/cardio.2019.12.n547
- Velasco A, Siddiqui M, Kreps E, et al. Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes. Hypertension. 2018;72(2):343-9. doi: 10.1161/HYPERTENSIONAHA.118.10965
- Dudenbostel T, Acelajado MC, Pisoni R, et al. Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure. Hypertension. 2015;66(1):126-33. doi: 10.1161/HYPERTENSIONAHA.115.05449
- Modolo R, Faria AP, Sabbatini AR, et al. Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic. J Am Soc Hypertens. 2015;9(5):397-402. doi: 10.1016/j.jash.2015.03.005
- Acelajado MC, Pisoni R, Dudenbostel T, et al. Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens. 2012;14:7-12. doi: 10.1111/j.1751-7176.2011.00556.x
- Calhoun DA, Booth JN 3rd, Oparil S, et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63:451-8. doi: 10.1016/j.jash.2015.03.005
- Armario P, Calhoun DA, Oliveras A, et al. Prevalence and clinical characteristics of refractory hypertension. J Am Heart Assoc. 2017;6(12):e007365. doi: 10.1161/JAHA.117.007365
- Buhnerkempe MG, Botchway A, Prakash V, et al. Prevalence of refractory hypertension in the United States from 1999 to 2014. J Hypertens. 2019;37(9):1797-804. doi: 10.1097/HJH.0000000000002103
- Mako K, Ureche C, Jeremias Z. Comparative evaluation of resistant and refractory hypertension clinical and ABPM data. J Hypertens. 2018;36:e53. doi: 10.1097/01.hjh.0000539109.65785.d3
- Huggett RJ, Scott EM, Gilbey SG, et al. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation. 2003;108:3097-101. doi: 10.1161/01.CIR.0000103123.66264.FE
- Landsberg L. Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A. 1990;12(5):817-30. doi: 10.3109/10641969009073502
- Mordi I, Mordi N, Delles C, Tzemos N. Endothelial dysfunction in human essential hypertension. J Hypertens. 2016;34(8):1464-72. doi: 10.1097/HJH.0000000000000965
- Власов Т.Д., Нестерович И.И., Шиманьски Д.А. Эндотелиальная дисфункция: от частного к общему. Возврат к «старой парадигме»? Регионарное кровообращение и микроциркуляция. 2019;18(2):19-27 [Vlasov TD, Nesterovich II, Shimanski DA. Endothelial dysfunction: from the particular to the general. Return to the «Old Paradigm»? Regional blood circulation and microcirculation. 2019;18(2):19-27 (In Russ.)]. doi: 10.24884/1682-6655-2019-18-2-19-27
- Подзолков В.И., Сафронова Т.А., Наткина Д.У. Эндотелиальная дисфункция у больных с контролируемой и неконтролируемой артериальной гипертензией. Терапевтический архив. 2019;91(9):108-14 [Podzolkov VI, Safronova TA, Natkina DU. Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension. Terapevticheskii Arkhiv (Ter. Arkh.). 2019;91(9):108-14 (In Russ.)]. doi: 10.26442/00403660.2019.09.000344
- Moreno B, de Faria AP, Ritter AMV, et al. Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. J Clin Hypertens. 2018;20:910-7. doi: 10.1111/jch.13293
- Hijmering ML, Stroes ES, Olijhoek J, et al. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol. 2002;39(4):683-8. doi: 10.1016/S0735-1097(01)01786-7
- Sheng Y, Zhu L. The crosstalk between autonomic nervous system and blood vessels. Int J Physiol Pathophysiol Pharmacol. 2018;10(1):17. PMID: 29593847
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi: 10.1093/eurheartj/ehy339
- Шляхто Е.В., Недогода С.В., Конради А.О. и др. Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний (национальные клинические рекомендации). СПб., 2017; с. 164. Режим доступа: https://scardio.ru/content/Guideli-nes/project/Ozhirenie_klin_rek_proekt.pdf. Ссылка активна на 19.01.2021 [Shlyahto EV, Nedogoda SV, Konradi AO, et al. Diagnosis, treatment, prevention of obesity and associated diseases (National Cinical Recommendations). Saint Petersburg, 2017; p. 164. Available at: http://scardio.ru/content/Guidelines/project/Ozhirenie_klin_rek_proekt.pdf. Accessed: 19.01.2021 (In Russ.)].
- Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111-5. doi: 10.1016/0140-6736(92)93147-F
- Thijssen DHJ, Bruno RM, van Mil ACCM, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534-47. doi: 10.1093/eurheartj/ehz350
- Затейщиков Д.А., Минушкина Л.О., Кудряшова О.Ю., Баринов В.Г. Функциональное состояние эндотелия у больных артериальной гипертонией и ишемической болезнью сердца. Кардиология. 2000;40(2):14-7 [Zatejshhikov DA, Minushkina LO, Kudrjashova OJu, Barinov VG. The functional state of the endothelium in patients with arterial hypertension and ischemic heart disease. Kardiologiia. 2000;40(2):14-7 (In Russ.)]
- Markus HS, Harrison M. Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath holding as the vasodilatory stimulus. Stroke. 1992;23:668-73. doi: 10.1161/01.str.23.5.668
- Lang R, Badano L, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-71. doi: 10.1093/ehjci/jev014
- Menon D, Arbique D, Wang Z, et al. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. J Clin Endocrinol Metab. 2009;94:1361-6. doi: 10.1210/jc.2008-2660
- Siddiqui M, Judd EK, Oparil S, Calhoun DA. White coat effect is uncommon in patients with refractory hypertension. Hypertension. 2017;70(3):645-51. doi: 10.1161/HYPERTENSIONAHA.117.09464
- Rayner BL, Spence JD. Hypertension in blacks: insights from Africa. J Hypertens. 2017; 35 (2): 234-239. doi: 10.1097/HJH.0000000000001171
- Jiang Y, Lu L, Hu Y, et al. Resistin induces hypertension and insulin resistance in mice via a tlr4-dependent pathway. Sci Rep. 2016;6:22193. doi: 10.1038/srep22193
- Petrica L, Vlad A, Gluhovschi G, et al. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study. J Diabetes Complications. 2015;29(2):230-7. doi: 10.1016/j.jdiacomp.2014.11.014
- Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens. 2010;19(2):195-200. doi: 10.1097/MNH.0b013e3283366cd0
- Atawia RT, Chen J, Toque HA, et al. Adipose tissue constituents and the adipokine resistin impair vascular endothelial function in obesity via elevated arginase activity. FASEB J. 2017;31(Suppl. 1):1065.10. doi: 10.1096/fasebj.31.1_supplement.1065.10
- Агаева Р.А., Данилов Н.М., Щелкова Г.В. и др. Радиочастотная денервация почечных артерий с применением различных устройств у пациентов с неконтролируемой артериальной гипертонией. Системные гипертензии. 2018;15(4):34-8 [Agaeva RA, Danilov NM, Shelkova GV, et al. Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension. Systemic Hypertension. 2018;15(4):34-8 (In Russ.)]. doi: 10.26442/2075082X.2018.4.000043
- Глыбочко П.В., Светанкова А.А., Родионов А.В. и др. Ренальная денервация при резистентной артериальной гипертензии: результаты 5-летнего наблюдения. Терапевтический архив. 2018;90(9):88-91 [Glybochko PV, Svetankova AA, Rodionov AV, et al. Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up. Terapevticheskii Arkhiv (Ter. Arkh.). 2018;90(9):88-91 (In Russ.)]. doi: 10.26442/terarkh201890988-91
- Савельева Н.Ю., Жержова А.Ю., Микова Е.В. и др. Радиочастотная денервация почечных артерий у больных резистентной артериальной гипертонией: трехлетний опыт наблюдения. Системные гипертензии. 2019;16(4):65-9 [Savelyeva NYu, Zherzhova AYu, Mikova EV, et al. Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience. Systemic Hypertension. 2019;16(4):65-9 (In Russ.)]. doi: 10.26442/2075082X.2019.4.190596
- Звартау Н.Э., Конради А.О. Интервенционные подходы к лечению артериальной гипертензии. Артериальная гипертензия. 2015;21(5):450-8 [Zvartau NE, Konradi AO. Update on interventional approaches to treatment of hypertension. Arterial Hypertension. 2015;21(5):450-8 (In Russ.)]. doi: 10.18705/1607-419X-2015-21-5-450-458.
- Чичкова Т.Ю., Мамчур С.Е. Ренальная денервация: обзор. Комплексные проблемы сердечно-сосудистых заболеваний. 2016;5(4):101-9 [Chichkova TJu, Mamchur SE. Renal denervation: a review. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2016;5(4):101-9 (In Russ.)]. doi: 10.17802/2306-1278-2016-4-101-109
- Фальковская А.Ю., Мордовин В.Ф., Пекарский С.Е. и др. Дополнительные благоприятные эффекты симпатической денервации почек при лечении резистентной артериальной гипертензии у больных сахарным диабетом 2-го типа. Артериальная гипертензия. 2014;20(2):107-12 [Falkovskaya AY, Mordovin VF, Pekarskiy SE, et al. Transcatheter renal denervation in patients with resistant hypertension and type 2 diabetes mellitus has beneficial effects beyond blood pressure reduction. Arterial Hypertension. 2014;20(2):107-12 (In Russ.)]. doi: 10.18705/1607-419X-2014-20-2-107-112
- Шугушев З.Х., Максимкин Д.А., Рюмина А.С. Возможности лечения больных резистентной артериальной гипертензией. Системные гипертензии. 2018;15(2):14-22 [Shugushev ZKh, Maximkin DA, Ryumina AS. Possibilities of treatment of patients with resistant arterial hypertension. Systemic Hypertension. 2018;15(2):14-22 (In Russ.)]. doi: 10.26442/2075-082X_2018.2.14-2
- Gupta P, Patel P, Strauch B, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017;70:1042-8. doi: 10.1161/HYPERTENSIONAHA.116.08729